logo

Exhibiting at VIV Asia 2025

3-44111
Bangkok
12 Mar - 14 Mar, 2025

Product Offerings

Products:

Veterinary Pharmaceuticals: Antibiotics, Antiparasitics, Anticoccidials

Feed Additives: Vitamins, Minerals, Probiotics

Disinfectants: Biocidal Products for Animal Facilities

Founded in Ankara, Turkey, Mistav İlaç Sanayi ve Ticaret Ltd. Şti. (also known as Mispharma) has emerged as a leading manufacturer and supplier of veterinary pharmaceuticals and feed additives. With a focus on delivering high-efficacy veterinary health products and biocidal disinfectants, Mistav caters to the needs of livestock producers, veterinary clinics, and animal health professionals across multiple international markets.

Core Business

Mistav specializes in the research, development, production, and distribution of veterinary pharmaceuticals, nutritional supplements, and hygiene solutions for the livestock industry. Their mission is centered on improving animal health and productivity through scientifically backed, high-quality formulations.

Product and Service Offerings

Mistav’s diverse product range includes:

  • Veterinary Pharmaceuticals

    • Antibiotics (injectable and oral formulations)
    • Antiparasitics (endoparasitic and ectoparasitic agents)
    • Anticoccidials
    • Anti-inflammatory and antipyretic medications
    • Injectable vitamin complexes (e.g., Vitamis AD3E)
  • Feed Additives

    • Multivitamin and mineral premixes
    • Probiotics and performance enhancers
    • Electrolyte solutions and appetite stimulants (e.g., Apromis-K)
  • Disinfectants

    • Biocidal solutions for animal housing and farm equipment
    • Formulations adhering to EU biocide regulations

Each product is manufactured under GMP-compliant conditions and undergoes rigorous quality control. Their veterinary line addresses the health challenges of poultry, cattle, sheep, goats, and companion animals.

Specialisation and Core USP

Mistav's core specialization lies in its focus on integrated animal health solutions—offering both curative pharmaceuticals and preventive feed-based interventions. A unique selling point is their custom-formulated solutions tailored to regional livestock diseases and nutritional deficiencies.

Their R&D team includes veterinarians and pharmacologists, enabling Mistav to respond swiftly to evolving disease trends in animal production, particularly in emerging markets.

Financial Strength and Growth

While Mistav operates as a private limited company and does not publicly disclose detailed financials, its expansion trajectory can be traced through international market penetration and export activities. According to regional trade data and industry publications:

  • Mistav has expanded its export footprint to over 15 countries, including Iraq, Azerbaijan, Sudan, Uzbekistan, and Libya.
  • The company has reported year-on-year double-digit growth in export volumes from 2020 to 2023, driven by increased demand in the Middle East and North Africa (MENA) region.

Shipment and Trade Data

According to verified export records from platforms such as Volza and ImportYeti:

  • Mistav completed over 200 international shipments between 2019–2023.
  • Major shipment destinations included Iraq, Libya, and Sudan, with average consignment values ranging between USD 8,000–20,000.
  • Key exported products included injectable vitamins, antiparasitic suspensions, and electrolyte powder formulations.

These figures highlight Mistav’s capacity to serve international B2B clients consistently with stable production and export compliance.

Target Market

Mistav’s products are targeted toward:

  • Veterinary clinics and hospitals
  • Livestock farms and poultry producers
  • Animal feed manufacturers and distributors
  • Government veterinary departments and NGOs
  • Export distributors and pharmaceutical wholesalers

The company emphasizes providing region-specific solutions, particularly for markets with tropical diseases, poor feed quality, or biosecurity challenges.

Capabilities

  • GMP-certified manufacturing plant in Ankara
  • Dedicated R&D unit for veterinary pharmacology
  • Customized formulation and contract manufacturing
  • Regulatory dossier support for international partners
  • Cold-chain logistics and export documentation services

The company also invests in technical training for veterinary staff and farm operators, enhancing end-user understanding and usage of its products.

Certifications and Compliance

Mistav adheres to national and international standards, with key certifications including:

  • GMP Certification from the Turkish Ministry of Agriculture and Forestry
  • ISO 9001:2015 Quality Management System
  • Biocidal Product Licensing for disinfectants under EU and Turkish regulations
  • Registered and authorized product dossiers for export in multiple countries

Customer Testimonials

A livestock cooperative in Iraq shared:

"Mistav's veterinary vitamin injections and probiotics have significantly improved our calf survival rates. We now trust them as a primary supplier."

A distributor in Libya mentioned:

"Their ability to deliver regulatory documents along with high-quality, competitively priced veterinary drugs has helped us scale our animal health business."

Major Achievements

  • Recognition by the Turkish Exporters Assembly for top-performing SME exporter in veterinary products (2022)
  • Expanded registration of 40+ SKUs in MENA and CIS markets
  • Launched a dedicated e-learning platform for veterinarians and farm advisors in 2023
  • Successfully introduced Colimo Oral Solution in 10 new countries in 2023 as part of their global growth initiative

Mistav İlaç continues to grow as a trusted partner for animal health, combining pharmaceutical expertise, localized solutions, and regulatory excellence to support sustainable livestock production worldwide.